Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells
Recruiting · NCT06967831 · Registry updated 2025-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Leigh syndrome, Nutritional and Metabolic Diseases, Pyruvate Metabolism, Inborn Errors, brain disorder, central nervous system disorder, contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inborn mitochondrial metabolism disorder, metabolic disease, nervous system disorder | Recruiting | Not stated | 2025-05-13 | NCT06967831 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Charite University, Berlin, Germany | 188 |
| European Union | 47 |
| German Federal Ministry of Education and Research | 30 |
| German Research Foundation | 24 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charite - Universtaetsmedizin Berlin | Berlin | Germany | 1 |
| Universitätsklinikum Düsseldorf | Düsseldorf | Germany | 11 |